Search
for

    Glossary Ixekizumab

    monoclonal antibody treating autoimmune conditions by targeting interleukin-17A

    Ixekizumab is a monoclonal antibody used to treat autoimmune conditions like psoriasis and psoriatic arthritis. It works by targeting and neutralizing interleukin-17A, a protein that plays a key role in inflammatory processes, thereby reducing symptoms and improving skin and joint health.

    Sort by

    Research 30 of 108

    1. Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab Journal of the American Academy of Dermatology · 2019 · 21 citations
    2. Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab JAAD case reports · 2021 · 3 citations
    3. 41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis Journal of the American Academy of Dermatology · 2023 · 2 citations
    4. Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis Journal of The American Academy of Dermatology · 2016 · 1 citations
    5. Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases Frontiers in Medicine · 2025
    6. Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib Journal of Inflammation Research · 2025
    7. Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up Clinical Cosmetic and Investigational Dermatology · 2024
    8. 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events Journal of the American Academy of Dermatology · 2023
    9. LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumab 2023
    10. Successful treatment of rare linear lichen planopilaris with Ixekizumab Journal of dermatological treatment · 2023
    11. Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis Journal of The American Academy of Dermatology · 2016
    12. New developments in the molecular treatment of ichthyosis: review of the literature Orphanet journal of rare diseases · 2022 · 21 citations
    13. Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives Psoriasis : Targets and Therapy · 2020 · 4 citations
    14. Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis JAAD Case Reports · 2020 · 3 citations
    15. Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    16. Cytokine-targeted treatment in alopecia areata - new possibilities? Prospects in Pharmaceutical Sciences · 2023 · 1 citations
    17. Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata 2023
    18. Hot topics in research and patient care in Dermatology and Venereology, 2019 Journal of The European Academy of Dermatology and Venereology · 2020
    19. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    20. Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge Dermatology Review · 2025
    21. Autoimmunity and autoimmune co-morbidities in psoriasis Immunology · 2018 · 49 citations
    22. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims Advances in Therapy · 2021 · 23 citations
    23. The role of diet in the management of psoriasis: a scoping review Nutrition Research Reviews · 2023 · 18 citations
    24. Guía clínica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo Revista médica de Chile · 2021 · 10 citations
    25. Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis Cureus · 2023 · 8 citations
    26. Therapeutic Application of Microsponges-based Drug Delivery Systems Current pharmaceutical design · 2022 · 4 citations
    27. Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review Archives of Dermatological Research · 2025 · 3 citations
    28. Assessing the burden of dermatological diseases on work life from a gender perspective Scientific Reports · 2025 · 2 citations
    29. Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis Dermatology Reports · 2026 · 1 citations
    30. Artificial Intelligence Deep Learning Ultrasound Discrimination of Cosmetic Fillers Journal of Ultrasound in Medicine · 2025 · 1 citations